| Published Application/Species/Sample/Dilution | Reference |
|---|
- flow cytometry; mouse; 1:200; loading ...; fig 1c
| Gejman R, Chang A, Jones H, DiKun K, Hakimi A, Schietinger A, et al. Rejection of immunogenic tumor clones is limited by clonal fraction. elife. 2018;7: pubmed publisher |
| Pérez Girón J, Gómez Medina S, Lüdtke A, Munoz Fontela C. Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity. J Vis Exp. 2015;:e52803 pubmed publisher |
| Hao H, Wu S, Lin J, Zheng Z, Zhou Y, Zhang Y, et al. Immunization against Zika by entrapping live virus in a subcutaneous self-adjuvanting hydrogel. Nat Biomed Eng. 2023;7:928-942 pubmed publisher |
| Li Y, Zhang H, Wang R, Wang Y, Li R, Zhu M, et al. Tumor Cell Nanovaccines Based on Genetically Engineered Antibody-Anchored Membrane. Adv Mater. 2023;35:e2208923 pubmed publisher |
| Ou W, Stewart S, White A, Kwizera E, Xu J, Fang Y, et al. In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nat Commun. 2023;14:392 pubmed publisher |
| Li J, Huang D, Lei B, Huang J, Yang L, Nie M, et al. VLA-4 suppression by senescence signals regulates meningeal immunity and leptomeningeal metastasis. elife. 2022;11: pubmed publisher |
| Malka Y, Alkan F, Ju S, K xf6 rner P, Pataskar A, Shulman E, et al. Alternative cleavage and polyadenylation generates downstream uncapped RNA isoforms with translation potential. Mol Cell. 2022;82:3840-3855.e8 pubmed publisher |
| Zhang Y, Sriramaneni R, Clark P, Jagodinsky J, Ye M, Jin W, et al. Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade. Nat Commun. 2022;13:4948 pubmed publisher |
| Yan J, Chen Y, Patel A, Warda S, Lee C, Nixon B, et al. Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses. J Clin Invest. 2022;132: pubmed publisher |
| Fusciello M, Yl xf6 sm xe4 ki E, Feola S, Uoti A, Martins B, Aalto K, et al. A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella. Mol Ther Oncolytics. 2022;25:137-145 pubmed publisher |
| Leary N, Walser S, He Y, Cousin N, Pereira P, Gallo A, et al. Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes. J Extracell Vesicles. 2022;11:e12197 pubmed publisher |
| Shen M, Smith H, Wei Y, Jiang Y, Zhao S, Wang N, et al. Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer. Nat Cancer. 2022;3:60-74 pubmed publisher |
| Song T, Long M, Zhao H, Zou M, Fan H, Liu Y, et al. Tumor evolution selectively inactivates the core microRNA machinery for immune evasion. Nat Commun. 2021;12:7003 pubmed publisher |
| Champagne J, Pataskar A, Blommaert N, Nagel R, Wernaart D, Ramalho S, et al. Oncogene-dependent sloppiness in mRNA translation. Mol Cell. 2021;81:4709-4721.e9 pubmed publisher |
| Sun L, Kees T, Almeida A, Liu B, He X, Ng D, et al. Activating a collaborative innate-adaptive immune response to control metastasis. Cancer Cell. 2021;39:1361-1374.e9 pubmed publisher |
| Zhang L, Huang J, Chen X, Pan C, He Y, Su R, et al. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response. J Immunother Cancer. 2021;9: pubmed publisher |
| Yl xf6 sm xe4 ki E, Fusciello M, Martins B, Feola S, Hamdan F, Chiaro J, et al. Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin. J Immunother Cancer. 2021;9: pubmed publisher |
| Pitsch J, Van Loo K, Gallus M, Dik A, Kamalizade D, Baumgart A, et al. CD8+ T-Lymphocyte-Driven Limbic Encephalitis Results in Temporal Lobe Epilepsy. Ann Neurol. 2021;89:666-685 pubmed publisher |
| Bartok O, Pataskar A, Nagel R, Laos M, Goldfarb E, Hayoun D, et al. Anti-tumour immunity induces aberrant peptide presentation in melanoma. Nature. 2021;590:332-337 pubmed publisher |
| Drijvers J, Gillis J, Muijlwijk T, Nguyen T, Gaudiano E, Harris I, et al. Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells. Cancer Immunol Res. 2021;9:184-199 pubmed publisher |
| Reguzova A, Ghosh M, M xfc ller M, Rziha H, Amann R. Orf Virus-Based Vaccine Vector D1701-V Induces Strong CD8+ T Cell Response against the Transgene but Not against ORFV-Derived Epitopes. Vaccines (Basel). 2020;8: pubmed publisher |
| Cordeiro B, Jeon P, Boukhaled G, Corrado M, Lapohos O, Roy D, et al. MicroRNA-9 Fine-Tunes Dendritic Cell Function by Suppressing Negative Regulators in a Cell-Type-Specific Manner. Cell Rep. 2020;31:107585 pubmed publisher |
| Tsuchiya N, Zhang R, Iwama T, Ueda N, Liu T, Tatsumi M, et al. Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells. Cell Rep. 2019;29:162-175.e9 pubmed publisher |
| Ahn J, Xia T, Rabasa Capote A, Betancourt D, Barber G. Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells. Cancer Cell. 2018;33:862-873.e5 pubmed publisher |
